• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.28% Nasdaq Up0.17%

    Sagent Pharmaceuticals, Inc. (SGNT)

    16.36 Down 0.24(1.45%) Oct 12, 4:00PM EDT
    ProfileGet Profile for:
    Sagent Pharmaceuticals, Inc.
    1901 North Roselle Road
    Suite 700
    Schaumburg, IL 60195
    United States - Map
    Phone: 847-908-1600
    Fax: 847-908-1601
    Website: http://www.sagentpharma.com

    Index Membership:N/A
    Industry:Drugs - Generic
    Full Time Employees:466

    Business Summary 

    Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, sources, manufactures, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in North America. The company offers anti-infective products, such as Cefepime, an antibiotic used to treat infections of the urinary tract, and skin and skin structures, as well as moderate to severe pneumonia, intra-abdominal infections, and as empiric therapy for febrile neutropenic patients; and Levofloxacin, a fluoroquinolone antibacterial for the treatment of infections caused by susceptible bacteria, including nosocomial and community acquired pneumonia, sinusitis, chronic bronchitis, skin and skin structure infections, prostatitis, urinary tract infection, and pyelonephritis in adults of age 18 years or older. It also provides oncology products consisting of Leucovorin Calcium, a folic acid derivative used to prevent harmful effects of methotrexate when methotrexate is used to treat certain types of cancer; and Zoledronic Acid, a bisphosphonate given intravenously to prevent skeletal fractures in patients with cancers, such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. In addition, the company offers critical care products comprising Heparin, an anticoagulant used to prevent and treat blood clotting during and after surgery and dialysis; and Propofol, a sedative used to induce and maintain general anesthesia during surgical procedures. As of December 31, 2014, its product portfolio included 54 marketed products. Sagent Pharmaceuticals, Inc. sells its products to hospitals, integrated delivery networks, and alternative site facilities through pharmaceutical wholesalers and specialty distributors. The company was formerly known as Sagent Holding Co. and changed its name to Sagent Pharmaceuticals, Inc. in April 2011. Sagent Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Schaumburg, Illinois.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Sagent Pharmaceuticals, Inc.

    Corporate Governance 
    Sagent Pharmaceuticals, Inc.’s ISS Governance QuickScore as of Oct 1, 2015 is 4. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 6; Compensation: 3.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Michael Logerfo , 51
    Pres, Chief Legal Officer and Corp. Sec.
    Mr. Jonathon M. Singer , 51
    Chief Financial Officer and Exec. VP
    Mr. Albert Patterson R.Ph., 72
    Exec. VP of National Accounts & Corp. Devel.
    Mr. Allan Oberman , 57
    Chief Exec. Officer and Director
    Mr. Jeffrey W. Greve , 40
    Principal Accounting Officer, VP and Controller
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders